Jones Day

Antitrust; Competition Law; Banking Law; Finance; Business Restructuring; Reorganization; Capital Markets; Corporate Criminal Investigations; Employee Benefits; Executive Compensation; Energy; Environmental Law; Health Law; Safety; Financial Institutions Litigation; Regulation; Government Regulation; Insurance Recovery; Health Care; Intellectual Property; International Litigation; Arbitration; Issues; Appellate Practice; Labor and Employment; Mergers and Acquisitions; Private Equity; Product Liability; Torts; Real Estate; Securities; Shareholder Litigation; Sec Enforcement; Tax Law; Trial Practice.

2011 California Labor and Employment Legislative Update
Aaron L. Agenbroad,Richard J. Bergstrom,George S. Howard,F. Curt Kirschner,Robert A. Naeve,Deborah Crandall Saxe,Steven M. Zadravecz, November 7, 2011
In early October, California Governor Jerry Brown signed a variety of important employment and labor-related statutes. Although Gov. Brown vetoed several additional anti-employer measures, this year marks a turning point for employers with workforces in California. We anticipate that the 2012...

Certain Post-Approval Activities to Support Submissions to the FDA Are Now Subject to Claims of Patent Infringement
Jonathan Berman,Anthony M. Insogna, September 22, 2011
On August 31, the Federal Circuit significantly restricted the scope of the "safe harbor" provision of 35 U.S.C. § 271(e)(1), which immunizes the use of patented inventions in connection with regulatory submissions to the Food and Drug Administration ("FDA"). Classen...

President Obama Proposes Reducing the Exclusivity Period of Brand-Name Biological Products
Jonathan Berman,Laura A. Coruzzi,Anthony M. Insogna, September 22, 2011
President Obama, in his new budget plan, proposes reducing the exclusivity period for brand-name biologics from 12 years to seven. The President would also limit the ability of manufacturers to obtain additional periods of exclusivity.

Return to the Jones Day Firm Overview